Phase 2 trial of palbociclib and ganitumab in patients with relapsed Ewing sarcoma

Category Primary study
JournalJournal of Clinical Oncology
Year 2022
This article has no abstract
Epistemonikos ID: 09942509f4e3830df9e06a1441954ddd2a07f617
First added on: Feb 15, 2025